Response
We thank Drs Dulak and Jozkowicz for their interest in our paper, 1 but we disagree with some of their arguments and interpretations. Drs Dulak and Jozkowicz stated that the sensitivity of detection for vascular endothelial growth factor (VEGF) differed in our 2 experiments, but it did not. They further state that we should have used an internal protein standard for normalization of the VEGF signals. The use of an internal protein standard assumes that the concentration of protein in the control and N G -nitro-L-arginine-methyl ester (L-NAME) groups was the same-an incorrect assumption because the total amount of protein in the interstitial fluid in the control group was different from that in the L-NAME group. To accurately estimate the concentration of VEGF in interstitial fluid, we normalized to volume in both groups, which should reflect the actual concentration in the myocardial interstitial fluid.
We also appreciate the information about the induction of VEGF expression by NO in cultured smooth muscle cells and in keratinocytes. [2] [3] [4] We do not dispute the results but remind Drs Dulak and Jozkowicz that extrapolation of results from experiments on cultured cells, which likely have a phenotype far different than those in vivo, is not a trivial matter. Moreover, the factors that drive VEGF expression in culture or in a skin-wound healing model may also be quite different from those involved in myocardial ischemia.
Finally, Drs Dulak and Jozkowicz stated that our results support the idea that the effects of NO on expression of VEGF may be different in the presence or absence of ischemia. We emphasize that in our model, repetitive coronary occlusions produce repeated episodes of myocardial ischemia, which induce the expression of VEGF. Basal expression of VEGF (in the absence of ischemia) is low. As coronary collaterals develop during the repetitive occlusions, the ischemic signal wanes, as does the expression of VEGF. When collateral growth is prevented by inhibition of NO synthesis, the level of ischemia is maintained during the occlusions, and the expression of VEGF remains elevated compared with basal levels. Importantly, during early periods of occlusion when the level of ischemia in the control and L-NAME groups is equivalent, the expression of VEGF is also equivalent. Thus, the expression of VEGF in the intact myocardium appears to be related to the presence of ischemia and not to the production of NO.
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